erythrosine has been researched along with diclofenac in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraff, MC; McGuigan, L; Raanan, MG; Sanders, DR | 1 |
| Ward, DA | 1 |
| Hwang, SH; Maitani, Y; Nagai, T; Qi, XR; Takayama, K | 1 |
| Finel, M; Häkli, M; Ketola, RA; Kidron, H; Manevski, N; Urtti, A; Wissel, G; Xhaard, H; Yliperttula, M | 1 |
| Castangia, I; Fadda, AM; Falchi, AM; Lampis, S; Manca, ML; Manconi, M; Valenti, D | 1 |
| Banga, AK; Bhattaccharjee, SA; Nguyen, HX; Puri, A | 1 |
| Bernstorff, S; Fernandes, E; Gonçalves, H; Lopes, CM; Lúcio, M; Real Oliveira, MECD; Soares, TB | 1 |
1 trial(s) available for erythrosine and diclofenac
| Article | Year |
|---|---|
Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Aqueous Humor; Blood; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Inflammation; Lenses, Intraocular; Male; Middle Aged; Postoperative Care; Prednisolone; Randomized Controlled Trials as Topic | 1990 |
6 other study(ies) available for erythrosine and diclofenac
| Article | Year |
|---|---|
Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Diclofenac; Dogs; Eye; Fluorescein; Fluoresceins; Fluorophotometry; Flurbiprofen; Ocular Physiological Phenomena; Ophthalmic Solutions; Random Allocation; Suprofen; Tolmetin | 1996 |
Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetates; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Carriers; Drug Compounding; Fluoresceins; Fluorescent Dyes; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Liposomes; Particle Size; Solutions | 1999 |
Impact of probe compound in MRP2 vesicular transport assays.
Topics: Acetaminophen; Animals; Baculoviridae; Biological Assay; Biological Transport; Budesonide; Cell Membrane; Cells, Cultured; Diclofenac; Disopyramide; Estradiol; Estrone; Fluoresceins; Genetic Vectors; Humans; Indomethacin; Inhibitory Concentration 50; Leukotriene C4; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Quercetin; Recombinant Proteins; Spodoptera; Statistics as Topic; Thioridazine; Transfection | 2012 |
Close-packed vesicles for diclofenac skin delivery and fibroblast targeting.
Topics: 3T3 Cells; Animals; Cell Death; Diclofenac; Drug Delivery Systems; Endocytosis; Fibroblasts; Fluoresceins; Fluorescence; In Vitro Techniques; Mice; Negative Staining; Particle Size; Permeability; Phosphatidylethanolamines; Rheology; Rhodamines; Scattering, Small Angle; Skin; Sus scrofa; Unilamellar Liposomes; X-Ray Diffraction | 2013 |
Qualitative and quantitative analysis of lateral diffusion of drugs in human skin.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Coloring Agents; Diclofenac; Diffusion; Fluoresceins; Humans; In Vitro Techniques; Lasers; Methylene Blue; Microinjections; Needles; Permeability; Skin; Skin Absorption | 2018 |
A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal Damage.
Topics: Biophysics; Diclofenac; Fluoresceins; Gastric Mucosa; Humans; Intestinal Mucosa; Models, Biological; Phospholipids | 2018 |